Published in Pharmazie on May 01, 1994
Cortical localization of dopamine D4 receptors in the rat brain--immunocytochemical study. J Physiol Pharmacol (2000) 1.04
Determination of the electric field gradient asymmetry from 2D nutation NQR spectra of 75As nuclei in oriented samples of As2Se3 semiconductor. Solid State Nucl Magn Reson (2007) 0.97
WAY 100135, an antagonist of 5-HT1A serotonin receptors, attenuates psychotomimetic effects of MK-801. Neuropsychopharmacology (2000) 0.89
Aryl hydrocarbon receptor-mediated apoptosis of neuronal cells: a possible interaction with estrogen receptor signaling. Neuroscience (2008) 0.87
Evidence that conditioned stress enhances outflow of dopamine in rat prefrontal cortex: a search for the influence of diazepam and 5-HT1A agonists. Synapse (1996) 0.83
Direct and indirect interactions between antidepressant drugs and CYP2C6 in the rat liver during long-term treatment. Eur Neuropsychopharmacol (2006) 0.82
Structure-activity relationship studies of central nervous system agents. 13. 4-[3-(Benzotriazol-1-yl)propyl]-1-(2-methoxyphenyl)piperazine, a new putative 5-HT1A receptor antagonist, and its analogs. J Med Chem (1994) 0.82
Ipsapirone enhances the dopamine outflow via 5-HT1A receptors in the rat prefrontal cortex. Eur J Pharmacol (1996) 0.82
Maternal separation affects the number, proliferation and apoptosis of glia cells in the substantia nigra and ventral tegmental area of juvenile rats. Neuroscience (2010) 0.82
Glutamatergic neurons of rat medial prefrontal cortex innervating the ventral tegmental area are positive for serotonin 5-HT1A receptor protein. J Physiol Pharmacol (2007) 0.81
Structure-activity relationship studies of CNS agents, Part 25. 4,6-di(heteroaryl)-2-(N-methylpiperazino)pyrimidines as new, potent 5-HT2A receptor ligands: a verification of the topographic model. Arch Pharm (Weinheim) (1995) 0.80
A search for colocalization of serotonin 5-HT2A and 5-HT1A receptors in the rat medial prefrontal and entorhinal cortices--immunohistochemical studies. J Physiol Pharmacol (2008) 0.79
Synthesis and evaluation of pharmacological properties of some new xanthone derivatives with piperazine moiety. Bioorg Med Chem Lett (2013) 0.79
The impact of maternal separation on the number of tyrosine hydroxylase-expressing midbrain neurons during different stages of ontogenesis. Neuroscience (2011) 0.78
Adaptive changes in the rat dopaminergic transmission following repeated lithium administration. J Neural Transm (Vienna) (1996) 0.78
5-HT1A receptors mediate detrimental effects of cocaine on long-term potentiation and expression of polysialylated neural cell adhesion molecule protein in rat dentate gyrus. Neuroscience (2009) 0.78
Structure-activity relationship studies of CNS agents--XVII. Spiro[piperidine-4',1-(1,2,3,4-tetrahydro-beta-carboline)] as a probe defining the extended topographic model of 5-HT1A receptors. Bioorg Med Chem (1995) 0.78
The corticosterone synthesis inhibitor metyrapone decreases dopamine D1 receptors in the rat brain. Neuroscience (1997) 0.78
Impact of metyrapone on MK-801-induced alterations in the rat dopamine D1 receptors. Pol J Pharmacol (1998) 0.77
1-(m-Chlorophenyl)piperazine: a metabolite of trazodone isolated from rat urine. J Pharm Pharmacol (1979) 0.77
The pharmacokinetics of promazine and its metabolites after acute and chronic administration to rats--a comparison with the pharmacokinetics of imipramine. Pol J Pharmacol (1996) 0.77
Structure-activity relationship studies of CNS agents. Part 9: 5-HT1A and 5-HT2 receptor affinity of some 2- and 3-substituted 1,2,3,4-tetrahydro-beta-carbolines. Pharmazie (1993) 0.77
Distribution of dopamine D1 receptors in the nucleus paraventricularis of the hypothalamus in rats: an immunohistochemical study. Brain Res Mol Brain Res (2000) 0.76
Metyrapone, an inhibitor of corticosterone synthesis, blocks the kainic acid-induced expression of HSP 70. Synapse (2000) 0.76
Pharmacokinetics of thioridazine and its metabolites in blood plasma and the brain of rats after acute and chronic treatment. Pol J Pharmacol (1998) 0.76
Single doses of MK-801, a non-competitive antagonist of NMDA receptors, increase the number of 5-HT1A serotonin receptors in the rat brain. Brain Res (1997) 0.76
Synthesis, anticonvulsant activity and 5-HT1A, 5-HT2A receptor affinity of new N-[(4-arylpiperazin-1-yl)-alkyl] derivatives of 2-azaspiro[4.4]nonane and [4.5]decane-1,3-dione. Eur J Med Chem (2006) 0.76
Synthesis and pharmacological properties of the products of condensation of tryptamine derivatives with pyridoxal. Pol J Pharmacol Pharm (1985) 0.75
Structure-activity relationship studies of CNS agents. Part 14: Structural requirements for the 5-HT1A and 5-HT2A receptor selectivity of simple 1-(2-pyrimidinyl)piperazine derivatives. Pharmazie (1994) 0.75
9-substituted 1,2,3,4-tetrahydro-beta-carbolin-1-ones, new 5-HT1A and 5-HT2A receptor ligands. Pol J Pharmacol (1999) 0.75
1-Pyridyl-3,4-dihydro-beta-carbolines: synthesis and central action. Pol J Pharmacol Pharm (1987) 0.75
[Hemolytic activity of selected strains of the genus Yersinia]. Med Dosw Mikrobiol (1985) 0.75
[Presence of enterotoxinogenic Enterobacteriaceae in children hospitalized for diarrhea at the Infectious Diseases Hospital in Warsaw]. Pediatr Pol (1978) 0.75
[The Presence of bacteria of the genus Yersinia in water from private wells]. Rocz Panstw Zakl Hig (1988) 0.75
[Biochemical aspects of the pathogenicity of Shigella. Protein components of aqueous extracts of virulent and non-virulent strains of Shigella flexneri]. Med Dosw Mikrobiol (1983) 0.75
Synthesis and pharmacological properties of some 2-substituted 1-(3-pyridyl)-1,2,3,4-tetrahydro-beta-carbolines. Pol J Pharmacol Pharm (1987) 0.75
Structure-activity relationship studies of CNS agents. XII. 1-[4-(4-aryl-1-piperazinyl)butyl]-3,4-dihydro-2(1H)-quinolinones: new 5-HT1A, 5-HT2 and D2 ligands with a potential antipsychotic activity. Drug Des Discov (1994) 0.75
Prolonged treatment with antidepressants increases the 5-HT1A-mediated inhibition of hippocampal neurons without changing the 5-HT1A receptor binding. Acta Physiol Hung (1996) 0.75
Substitution mode of the amide fragment in some new N-[omega-[4-(2-methoxyphenyl)piperazin-1-yl]alkyl]pyrid-2(1H)-ones and their 5-HT1A/5-HT2A activity. Pol J Pharmacol (2002) 0.75
Structure-activity relationship studies of CNS agents. Part 38. Novel 1,4-benzoxazin-3(4H)-one, 1,2-benzoxazolin-3-one and 1,3-benzoxazolin-2,4-dione arylpiperazine derivatives with different 5-HT1A and antagonistic 5-HT2A activities. Arch Pharm (Weinheim) (1999) 0.75
Structure-activity relationship studies of CNS agents, Part 23: N-(3-phenylpropyl)- and N-[(E)-cinnamyl]-1,2,3,4-tetrahydroisoquinoline mimic 1-phenylpiperazine at 5-HT1A receptors. Arch Pharm (Weinheim) (1996) 0.75
1,2,3,4-tetrahydroisoquinoline derivatives: a new class of 5-HT1A receptor ligands. Bioorg Med Chem (1999) 0.75
[Elimination of practolol in uremia]. Wiad Lek (1980) 0.75
[The role of the midwife in decreasing the number of abortions]. Pieleg Polozna (1988) 0.75
Imipramine increases the 5-HT1A receptor-mediated inhibition of hippocampal neurons without changing the 5-HT1A receptor binding. Eur J Pharmacol (1996) 0.75
[Temperature-related production of enterotoxin by Yersinia enterocolitica isolated from healthy swine]. Med Dosw Mikrobiol (1988) 0.75
MP-3022, a new putative antagonist at pre- and postsynaptic 5-HT1A receptors. Pol J Pharmacol (1997) 0.75
The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.75
Structure-activity relationship studies of CNS agents. Part 16: A lower limit of a distance between crucial pharmacophores of 5-HT1A ligands. Pharmazie (1994) 0.75
Structure-activity relationship studies of CNS agents, XIX: Quantitative analysis of the alkyl chain effects on the 5-HT1A and 5-HT2 receptor affinities of 4-alkyl-1-arylpiperazines and their analogs. Arch Pharm (Weinheim) (1995) 0.75
8-[4-[2-(1,2,3,4-Tetrahydroisoquinolinyl]butyl-8-azaspiro[4.5]decane-7,9-dione: a new 5-HT1A receptor ligand with the same activity profile as buspirone. J Med Chem (1996) 0.75
New synthesis of 5-nitro- and 5-benzyloxytryptamine and their N-acylderivatives. Pol J Pharmacol Pharm (1985) 0.75
Structure-activity relationship studies of CNS agents, XXI: Two derivatives of 1-(o-methoxyphenyl)piperazine with an opposite function at 5-HT1A receptors. Arch Pharm (Weinheim) (1995) 0.75
Molecules as complex adaptative systems: constrained molecular properties and their biochemical significance. Eur J Pharm Sci (2000) 0.75
Synthesis and pharmacological properties of some 2-(3-aminopropionyl)- and 2-(3-aminopropyl)-1-(3-pyridyl)-1,2,3,4-tetrahydro-beta-carbolines. Pol J Pharmacol Pharm (1989) 0.75
[Evaluation of selective properties of Mac Conkey's medium enriched with potassium tellurite for growing Shigella and Yersinia strains]. Med Dosw Mikrobiol (1988) 0.75
4-Aryl-1-piperazinylalkyl derivatives of 1,2,3,4-tetrahydro-beta-carboline ring system. Synthesis and preliminary in vivo studies. Pharmazie (1996) 0.75
Arylpiperazine derivatives of 3-propyl-beta-tetralonohydantoin as new 5-HT1A and 5-HT2A receptor ligands. Pol J Pharmacol (2002) 0.75
Structure-activity relationship studies of CNS agents. Part VIII. Bulk tolerance around the protonation center of 4-substituted 1-(3-chlorophenyl)piperazines at 5-HT1A and 5-HT2 receptors. Pol J Pharmacol Pharm (1993) 0.75
Synthesis and pharmacological properties of some N-aroylhomotryptamines. Pol J Pharmacol Pharm (1979) 0.75